Recent Publications

PURE: Perceived built environment characteristics associated with walking and cycling across 355 communities in 21 countries

Cities: The International Journal of Urban Policy & Planning

K Boakye, M Bovbjerg, J Schuna, A Branscum, N Mat-Nasir, A Bahonar, O Barbarash, R Yusuf, P Lopez-Jaramillo, P Seron, A Rosengren, K Yeates, J Chifamba, KF Alhabib, K Davletov, MV Keskinler, M Diaz, L Kruger, Y Li, L Zhiguang, LA Tse, A Wielgosz, K Teo, M Erkin, S Rangarajan, S Lear, S Yusuf, P Hystad

November 2022

COMPASS: The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices

Expert Review of Pharmacoeconomics & Outcomes Research

F Yuan, SI Bangdiwala, W Tong, A Lamy

November 2022

COMPASS: Comparison of investigator-reported vs centrally adjudicated major adverse cardiac events – a secondary analysis of the trial

JAMA Network Open

P Gaba, DL Bhatt, GR Dagenais, J Bosch, AP Maggioni, P Widimsky, D Leong, KAA Fox, S Yusuf, JW Eikelboom

November 2022

START, BiB: Gestational diabetes genetic risk in South Asian women

eLife

A Lamri, J Limbachia, KM Schulze, D Desai, B Kelly, RJ de Souza, G Pare, DA Lawlor, J Wright, SS Anand

November 2022

CarDIA: Centralized triage of suspected coronary artery disease using coronary computed tomographic angiography to optimize the diagnostic yield of invasive angiography

CJC Open

JD Schwalm, Z Bouck, MK Natarajan, N Pinilla, D Walker, N Syed, D Landry, A Sabri, V Tandon, J Nkurunziza, M Talijaard, T Sheth

November 2022

TIPS-3: Vitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk

Nutrition, Metabolism & Cardiovascular Diseases

P Joseph, P Pais, P Gao, K Teo, D Xavier, P Lopez-Jaramillo, K Yusoff, A Santoso, H Gamra, SH Talukder, C Christou, G Dagenais, J Tyrwhitt, J Bosch, A Dans, S Yusuf

November 2022

IVVE: Randomized trial of influenza vaccine in heart failure to reduce adverse vascular events

Lancet Global Health

M Loeb, A Roy, H Dokainish, A Dans, LM Palileo-Villanueva, K Karaye, J Zhu, Y Liang, F Goma, A Damasceno, KF Alhabib, G Yonga, C Mondo, W Almahameed, A Al Mulla, V Thanabalan, P Rao-Melacini, A Grinvalds, T McCready, SI Bangdiwala, S Yusuf

November 2022

ATLAS S-ICD: Perioperative safety and early patient and device outcomes among subcutaneous versus transvenous ICD implantation: a randomized, multi-center trial

Annals of Internal Medicine

JS Healey, AD Krahn, J Bashir, G Amit, F Philippon, WF McIntyre, B Tsang, J Joza, DV Exner, DH Birnie, M Sadek, DP Leong, M Sikkel, V Korley, JL Sapp, JF Roux, SF Lee, G Wong, A Djuric, D Spears, S Carroll, E Crystal, T Hruczkowski, SJ Connolly, B Mondesert

November 2022

Consumer-led screening for atrial fibrillation: Frontier review of the AF-SCREEN International Collaboration

AHA Circulation

A Brandes, S Stavrakis, B Freedman, Sotiris Antoniou, G Boriani, J Camm, CK Chow, E Ding, J Engdahl, MM Gibson, G Golovchiner, T Glotzer, Y Guo, JS Healey, MT Hills, L Johnson, GYH Lip, T Lobban, PW Macfarlane, GM Marcus, DD McManus, L Neubeck, J Orchard, MV Perez, RB Schnabel, B Smyth, S Steinhubl, MP Turakhia

November 2022

TIPS-3: Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease

Kidney International

JFE Mann, P Joseph, P Gao, P Pais, J Tyrwhitt, D Xavier, T Dans, P Lopez Jaramillo, H Gamra, S Yusuf

November 2022

INTERSTROKE: Alcohol intake as a risk factor for acute stroke

Neurology

A Smyth, M O'Donnell, S Rangarajan, GJ Hankey, S Oveisgharan, M Canavan, C McDermott, D Xavier, H Zhang, A Damasceno, A Avezum, N Pogosova, A Oguz, D Ryglewicz, HK Iversen, F Lanas, A Rosengren, S Yusuf

October 2022

REWIND: Does dulaglutide impact a composite outcome reflecting atherosclerosis? A post-hoc analysis

European Heart Journal

G Ferrannini, L Mellbin, F Kirabo, C Ramasundarahettige, H Gerstein, L Ryden

October 2022

The polypill – concept to evidence; next step – implementation

The Lancet

Salim Yusuf and Fausto Pinto

October 2022

ACT: Colchicine and aspirin in community patients with COVID-19: an open-label, factorial, randomised, controlled trial

Lancet Respiratory Medicine

JW Eikelboom, SS Jolly, EP Belley-Cote, RP Whitlock, S Rangarajan, L Xu, L Heenan, SI Bangdiwala, WM Tarhuni, M Hassany, A Kontsevaya, W Harper, SK Sharma, P Lopez-Jaramillo, AL Dans, LM Palileo-Villanueva, A Avezum, P Pais, D Xavier, C Felix, A Yusufali, RD Lopes, O Berwanger, Z Ali, S Wasserman, SS Anand, J Bosch, S Choudhri, ME Farkouh, M Loeb, S Yusuf

October 2022

ACT: Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19: an open-label, factorial, randomised, controlled trial

Lancet Respiratory Medicine

J Eikelboom, SS Jolly, EP Belley-Cote, RP Whitlock, S Rangarajan, L Xu, L Heenan, SI Bangdiwala, ML Diaz, R Diaz, A Yusufali, SK Sharma, WM Tarhuni, M Hassany, A Avezum, W Harper, S Wasserman, A Almas, O Drapkina, C Felix, RD Lopes, O Berwanger, P Lopez-Jaramillo, SS Anand, J Bosch, S Choudhri, S Choudhri, ME Farkouh, M Loeb, S Yusuf

October 2022

Cities: The International Journal of Urban Policy & Planning

Expert Review of Pharmacoeconomics & Outcomes Research

JAMA Network Open

eLife

CJC Open

Nutrition, Metabolism & Cardiovascular Diseases

Lancet Global Health

Annals of Internal Medicine

AHA Circulation

Kidney International

Neurology

European Heart Journal

The Lancet

Lancet Respiratory Medicine

Lancet Respiratory Medicine

Sign up for the PHRI Pulse Newsletter